Viewing Study NCT05056558


Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2025-12-30 @ 6:09 PM
Study NCT ID: NCT05056558
Status: UNKNOWN
Last Update Posted: 2021-09-28
First Post: 2021-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19
Sponsor: Incepta Pharmaceuticals Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module